Geoffrey M. Parker - Jun 7, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Stock symbol
BTTX
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 06:55 PM
Previous filing
May 19, 2023
Next filing
Jun 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTTX Stock Option (Right to Buy) Award $0 +15 K $0.00 15 K Jun 7, 2023 Common Stock 15 K $0.77 Direct F1

Explanation of Responses:

Id Content
F1 The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023.